The ongoing legal battle between three leading pharmacy benefit managers (PBMs) — Express Scripts, Caremark, and Optum Rx — and the Federal Trade Commission (FTC) has garnered substantial attention. The core of the dispute revolves around allegations that these PBMs have engaged in anticompetitive
The British Columbia (BC) Government has recently introduced a series of stringent regulations aimed at addressing the province's escalating drug crisis. These measures focus on ensuring the safe consumption of prescribed alternatives, enhancing oversight of pharmacies, and providing comprehensive
The recent job cuts in U.S. health agencies, particularly those under the Department of Health and Human Services (HHS), have sparked significant concern among public health experts and industry professionals. These layoffs, driven by the Trump administration's policies, could have far-reaching
The recent confirmation of Robert F. Kennedy Jr. as the Secretary of Health and Human Services (HHS) has sparked significant debate and concern within the healthcare community. Known for his controversial stance on vaccine safety, Kennedy's appointment raises questions about the future direction of
House Republicans have recently unveiled a budget resolution aiming to enact $1.5 trillion in cuts, with significant portions potentially affecting healthcare programs, specifically targeting Medicaid. This budget proposal is a crucial starting point for legislative negotiations and is marked by
The recent advancement of Robert F. Kennedy Jr.'s nomination as U.S. health secretary has ignited significant debate and concerns, particularly regarding his controversial stance on vaccines. The Senate Finance Committee's narrow 14-13 vote along party lines, with all Republicans endorsing Kennedy,
